CytomX Therapeutics
CTMX
CTMX
90 hedge funds and large institutions have $343M invested in CytomX Therapeutics in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $332M → $343M (+$11.1M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
90
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$12.4M | |
| 2 | +$9.73M | |
| 3 | +$3.45M | |
| 4 |
Renaissance Technologies
New York
|
+$2.73M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.56M |
Top Sellers
| 1 | -$2.89M | |
| 2 | -$2.17M | |
| 3 | -$1.83M | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$1.59M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.29M |